4-[(dimethylamino)methyl]-4-azepanol, 95.0%, 250mg

Methyl 4-amino-3-iodobenzoate, 95.0%, 5g

1,2-Pyrrolidinedicarboxamide, N1-[2-(1,1-dimethylethyl)-4'-methyl[4,5'-bithiazol]-2'-yl]-, (2S)-, 98%, 5mg

3-Bromonaphtho[2,3-b]benzofuran, 98%, 5g

(2,5-Difluoro-4-formylphenyl)boronic acid, 95%, 1g

4-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-amine hydrochloride, 97.0%, 250mg

(S)-1-Benzyl 4-methyl 2-((tert-butoxycarbonyl)amino)succinate, 95%, 250mg

4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexenyl]methyl]-1-piperazinyl]benzoic Acid Hydrochloride, 97.0%, 1g

(3-Chloro-5-cyanophenyl)boronic acid, 95.0%, 250mg

Methyl 2-chlorothiazole-5-carboxylate, 95.0%, 25g

Fexofenadine Hydrochloride>98.0%(HPLC)(T)1g

2-Cyano-5-fluoropyridine>98.0%(GC)1g

Ácido D(-)-tartárico, mínimo 99 %, para bioquímica, 25 g, envase de plástico.